Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17090213.
- Also identified by PMC identifier 1630715.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability.
Medical subject headings
- Anti-Retroviral Agents
- Clinical Trials as Topic
- HIV Infections